• Home
  • About Us
    • Board of Directors
    • Board Committees
  • Products
    • Anti Biotics & Anti Infectives
    • Beta-lactams- Penicillins
    • Antifungals
    • Miscellaneous
    • Vitamins & Supplements
    • Cardiovasculars
    • Antipyretic, Analgesic, NSAIDs
    • Antacid, Anti-Ulcer Drugs
    • Antidepressants, Antipsychotics
    • Antimalarials
    • Dry Syrups
    • Ointments & Creams
    • Anti-Diabetics
    • Syrups
  • Investors Relation
    • General Meetings
    • Shareholding Pattern
    • Stock Exchange Intimation
    • Investor Complaints
    • Investor Relation Announcements
    • Attendence Sheet & Proxy Form
    • Annual Report
    • Financials Results
    • Unpaid / Unclaimed Dividend
    • Policies
    • Memorandum of Association (MOA) and Articles of Association (AOA)
    • Integrated Filing - Governance
  • Contact Us

Investor Relation Announcements


pdf-30Related Party Transactions - 31st March, 2025

pdf-30Newspaper Publication_Audited Financial Results_31 March 2025

pdf-30Newspaper Publication_Unaudited Financial Results_31st December 2024

pdf-30Related Party Transactions - 30th September, 2024

pdf-30Newspaper Publication_Unaudited Financial Results_30 September

pdf-30Newspaper Publication_Unaudited Financial Results_30 June 2024

pdf-30Newspaper Publication_Audited Financial Results_31 March 2024

pdf-30Related Party Transactions - 31st March, 2024

pdf-30Newspaper Publication_Unaudited Financial Results_30 September 2023

pdf-30Related Party Transactions - 30th September, 2023

pdf-30Newspaper Publication_Unaudited Financial Results_30 June 2023

pdf-30Newspaper publication_Audited Financial Results-31 March 2023

pdf-30Related Party Transactions- 31st March, 2023

pdf-30Intimation of Record date for Split of Equity Shares

pdf-30Newspaper publication_Unaudited Financial Results_31 December 2022

pdf-30Related Party Transactions 30th September 2022

pdf-30 Newspaper publication_Unaudited Financial Results_30 September 2022

pdf-30 Newspaper publication_Unaudited Financial Results 30 June 2022

pdf-30 Issuance Of Bonus Shares -Record Date

pdf-30 Format of Initial Disclosure to be made by an entity identified as a Large Corporate

pdf-30 Regulation 13(3) June 2021

pdf-30 2b. Regulation 13(3) March 2021

pdf-30 Regulation 13(3) December 2020

pdf-30 Regulation 13(3) September 2020

pdf-30 AUTHORISATION TO FILE WITH STOCK EXCHANGE

pdf-30 Regulation 30- Resignation of Shweta


Our Company, Medico Remedies Limited, is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums.

Contact info

  • Medico Remedies Limited
    Harshit Mehta(Director) 1105/1106, Hubtown Solaris, N.S.Phadke Marg, opp.teligali, Andheri East ,
    Mumbai-400069.
  • +91-22- 68943803
  • secretarialmrl@gmail.com

Link

  • About Us
  • Investor
  • Products
  • Contact Us

Connect With Us

©Copyright 2017 Medico Remedies Ltd : Design by :- Find Solution